78981-67-6

Usage

Uses

Used in Pharmaceutical Industry:
L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its role in this industry is crucial for creating complex molecular structures that can target specific biological pathways.
Used in Agrochemical Industry:
In the agrochemical sector, L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is utilized as a component in the formulation of pesticides, herbicides, and other agricultural chemicals. Its inclusion in these products can enhance their effectiveness and selectivity, leading to improved crop protection.
Used in Fragrance Industry:
L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is used as a building block in the creation of fragrances, where it contributes to the development of unique scents and aromas. Its versatility in this application allows for the production of a wide range of fragrances for various consumer products.
Used in Sports Nutrition:
L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is used as a supplement in sports nutrition for its potential to enhance muscle growth and athletic performance. Its role in this application is to support the body's protein synthesis and recovery processes, which can be beneficial for athletes and fitness enthusiasts.
Used in Organic Synthesis:
In the field of organic synthesis, L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is employed as a versatile reagent and building block for the creation of a variety of organic compounds. Its chemical properties make it suitable for use in numerous synthetic pathways, contributing to the development of new chemical entities.
Used in Medicinal Chemistry:
L-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-valyl]-, methyl ester is utilized in medicinal chemistry as a key component in the design and synthesis of potential drug candidates. Its unique structure allows for the exploration of new therapeutic agents that can target a range of diseases and conditions.

Downstream Products

• 84559-75-1 N-(D-valylleucyllysyl)-N',N'-bis(2-chloroethyl)-p-phenylenediamine bis(trifluoroacetate) 
• 84559-77-3 N-(D-valylleucyl-D-lysyl)-N',N'-bis(2-chloroethyl)-p-phenylenediamine bis(trifluoroacetate) 
• 84559-73-9 N-α-(tert-buthoxycarbonyl)-D-valylleucyl-N^ε-(tert-buthoxycarbonyl)lysyl>-N',N'-bis(2-chloroethyl)-p-phenylenediamine 
• 84559-74-0 N-α-(tert-buthoxycarbonyl)-D-valylleucyl-N^ε-(tert-buthoxycarbonyl)-D-lysyl>-N',N'-bis(2-chloroethyl)-p-phenylenediamine 
• 183444-81-7 {(S)-5-(2-Benzyloxycarbonylamino-ethylcarbamoyl)-5-[(S)-2-((R)-2-tert-butoxycarbonylamino-3-methyl-butyrylamino)-4-methyl-pentanoylamino]-pentyl}-carbamic acid tert-butyl ester